SAN RAMON, Calif., October 16, 2025 — Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering fetal monitoring innovations through advanced biophotonics and machine learning, today announced the successful completion of a 35-patient Early Feasibility Study (EFS) at Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School (EVMS) at Old Dominion University.
